LIGANDROL (LGD-4033) Solution, 300mg (10mg/mL)

  • Sale
  • €46,99
  • Regular price €55,00
Tax included. Shipping calculated at checkout.


LIGANDROL (LGD-4033)

LGD 4033 is a SARM that is more commonly known by the name Ligandrol but has also been called VK5211 or Anabolicum. In various animal studies, LGD 4033 has been shown to increase anabolic activity in the muscles and have positive effects on bone density in male rats experiencing hypogonadism, and have success treating female postmenopausal rats experiencing osteoporosis.

 

LGD 4033 Bone and Muscle Effects

Additionally, various studies presented at the 62nd Annual Meeting of the Gerontology Society of America, found that use with LGD 4033 in animals increased resistance to fracture and bone mineral density after 12 weeks. This increase was noted in cancellous bone after a dose of 0.3 mg/kg per day and noted in cortical bone after a dose of 0.03 mg/kg per day (https://www.sec.gov/Archives/edgar/data/886163/000119312509239917/d425.htm).

 

Furthermore, in both hypogonadal rats and normal rats LGD 4033 use was seen to increase skeletal muscle mass and muscle fiber diameter correlating to contractile power of the muscle which indicates greater muscle strength.

 

In a fascinating study conducted by Roch et. Al, 3-month-old Sprauge-Dawley rats were ovariectomized and given LGD 4033 for 5 weeks. Each rat in the experimental groups was given doses of either 0.04, 0.4 or 4 mg/kg of body weight/day. After use, the researchers conducted an analysis of fiber size, capillary density, and various enzyme levels, additionally, the uterus, gastrocnemius, and soleus muscles were all weighed to document any changes before and after use   (https://www.frontiersin.org/articles/10.3389/fendo.2020.556581/full#B30).

 

When determining the effects of the LGD 4033 on the rats, researchers took samples from the quadriceps femoris muscle in order to determine changes in intramuscular fat content. In addition to determining changes in the intramuscular fat content, it was found that with treatment with LGD 4033 there was higher capillary density.

 

Furthermore, with LGD 4033, there was higher activity of the enzyme citrate synthase in the gastrocnemius muscle. It was also found that after testing, the activity of the enzyme lactate dehydrogenase was higher in the longissimus muscle (https://www.frontiersin.org/articles/10.3389/fendo.2020.556581/full#B30).

 

Overall, animal research with LGD 4033 had a uterotrophic effect when subjects were given a 4 mg dosage, beneficial effects on muscle vascularization as well as muscle metabolism were also found following use. Additionally, after the 4 mg dosage of LGD 4033, researchers reported increased muscular weight and increased weight of intramuscular fat content.

Concentration

10mg/ml.

Half Life

24 – 36 hours.

DISCLAIMER

This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or domestic use. Please familiarize yourself with our DISCLAIMER before ordering.

Data Sheet

LIGANDROL (LGD-4033) Solution, 300mg (10mg/mL)

Application Selective Androgen Receptor Modulator
CAS 1165910-22-4
Molar Mass 338.25 g/mol
Chemical Formula C14H12F6N2O
IUPAC Name 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile
Synonyms LG4, LG-4, 1165910-22-4, UNII-1EJT54415A, 4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile, 1EJT54415A, 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile, 4-{(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl}-2-(trifluoromethyl)benzonitrile, SCHEMBL221159, DTXSID10657620, EX-A729, PUBCHEM_44137686, BCP07128, s8822, ZINC95830588, AKOS022173564, CS-4667, DB13934, AC-30218, AK141891, HY-13981, AX8259791, A14346, J-690039, Q21098841, 4-[(2R)-2-[(1R)-2,2,2-TRIFLUORO-1-HYDROXYETHYL]PYRROLIDIN-1-YL]-2-(TRIFLUOROMETHYL)BENZONITRILE, Benzonitrile, 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)-
Storage Room temperature
Solubility Soluble in Ethanol, PEG400, PG, Glycerin
Organoleptic Profile Slightly Occluded Clear Liquid
Physical Form Solution in PEG400
Specification 10mg/mL ±5%
Terms This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.

Customer Reviews

Based on 2 reviews Write a review

English

Hi there

Welcome Guest
We typically reply within minutes
James
Hello! James here from Support team,this is sample text. Original text will display as per app dashboard settings